DrugPatentWatch Database Preview
APOKYN Drug Profile
or, see our see our flat-rate plans
Which patents cover Apokyn, and when can generic versions of Apokyn launch?
The generic ingredient in APOKYN is apomorphine hydrochloride. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the apomorphine hydrochloride profile page.
Summary for APOKYN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 47 |
| Clinical Trials: | 5 |
| Patent Applications: | 3,448 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | APOKYN at DailyMed |
Pharmacology for APOKYN
| Drug Class | Dopaminergic Agonist |
| Mechanism of Action | Dopamine Agonists |
Medical Subject Heading (MeSH) Categories for APOKYN
Synonyms for APOKYN
| (-)-10,11-Dihydroxyaporphine |
| (-)-Apomorphine |
| (-)-Apomorphine (hydrochloride) |
| (-)-Apomorphine hydrochloride |
| (-)-Apomorphinium hydrochloride |
| (-)6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol(APO) |
| (6aR)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo(de,g)chinolin-10,11-diol |
| (6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol |
| (6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol hydrochloride |
| (6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol;hydrate;hydrochloride |
| (9R)-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2,4,6,13,15-hexaene-3,4-diol |
| (9R)-10-methyl-10-azatetracyclo[7.7.1.0;{2,7}.0;{13,17}]heptadeca-1(16),2(7),3,5,13(17),14-hexaene-3,4-diol |
| (Apomorphine) 6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol |
| (apomorphine)6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol |
| (R)-(-)-Apomorphine |
| (R)-(-)-apomorphine HCl |
| (R)-(-)-Apomorphine hydrochloride |
| (R)-5,6,6A,7-TETRAHYDRO-6-METHYL-4H-DIBENZO[DE-G]QUINOLINE-10,11-DIOL |
| (R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol hydrochloride |
| (R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol |
| (R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol ((R)-apomorphine) |
| (R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol (apomorphine) |
| (R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol(apomorphine) |
| (R)-Apomorphine |
| 314-19-2 |
| 314-19-2 (hydrochloride anhydrous) |
| 372A207 |
| 41372-20-7 |
| 41372-20-7 (hydrochloride hemihydrate) |
| 4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, (R)- |
| 4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, (R)- (9CI) |
| 4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, hydrochloride (1:1), (6aR)- |
| 4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, hydrochloride, (6aR)- |
| 4H-Dibenzo[de,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, hydrochloride, (R)- |
| 5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo(de,g)chinolin-10,11-diol hydrochlorid |
| 58-00-4 |
| 58-00-4 (Parent) |
| 5896-07-1 |
| 6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol ((R)-apomorphine) |
| 6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol((R)-apomorphine) |
| 6a-beta-Aporphine-10,11-diol |
| 6a-beta-Aporphine-10,11-diol, hydrochloride |
| 6a-beta-Noraporphine-10,11-diol, 6-methyl-, hydrochloride |
| 6a.beta.-Aporphine-10, hydrochloride |
| 6a.beta.-Noraporphine-10, 6-methyl-, hydrochloride |
| 6abeta-Aporphine-10,11-diol |
| 6abeta-Aporphine-10,11-diol, hydrochloride |
| 6abeta-Aporphine-10,11-diol, hydrochloride (8CI) |
| 6abeta-Noraporphine-10,11-diol, 6-methyl-, hydrochloride |
| 8233AH |
| 9K13MD7A0D |
| AC1L1LLC |
| AC1L1SZ7 |
| AC1Q3F8P |
| AKOS024456928 |
| API0001523 |
| Apomorfin |
| Apomorphin |
| Apomorphin hydrochlorid |
| apomorphine |
| Apomorphine (BAN) |
| Apomorphine (intranasal, Parkinson's disease) |
| Apomorphine (R,-) |
| Apomorphine [BAN] |
| Apomorphine chloride |
| Apomorphine HCl |
| Apomorphine hydrochloride |
| Apomorphine Hydrochloride (anhydrous) |
| Apomorphine hydrochloride (R,-) |
| Apomorphine hydrochloride anhydrous |
| Apomorphine hydrochloride hemihydrate |
| Apomorphine hydrochloride hydrate |
| Apomorphine Hydrochloride, Anhydrous |
| Apomorphine SL |
| apomorphine-hcl |
| APOMORPHINE, HYDROCHLORIDE |
| APOMORPHINE6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol |
| APOMORPHINEHYDROCHLORIDE |
| Apomorphinium chloride |
| Apomorphinium chloride hemihydrate |
| Apomorphinum hydrochloricum |
| Apormorphine |
| B6936 |
| BB_NC-0484 |
| BDBM29644 |
| BDBM50001955 |
| BG0043 |
| Biomol-NT_000019 |
| BPBio1_000092 |
| BPBio1_001179 |
| BRD-K76022557-001-01-3 |
| BRD-K76022557-311-20-6 |
| BSPBio_000082 |
| C17H17NO2 |
| C17H17NO2.HCl |
| CAS-58-00-4 |
| CHEBI:48538 |
| CHEMBL1616 |
| CHEMBL53 |
| cid_6852399 |
| CTK8F2000 |
| D07460 |
| D0B6QP |
| D0H6QU |
| DB00714 |
| DSSTox_CID_2614 |
| DSSTox_GSID_22614 |
| DSSTox_RID_76660 |
| DTXSID5040598 |
| DTXSID8022614 |
| EINECS 200-360-0 |
| EINECS 206-243-0 |
| FT-0602881 |
| GTPL33 |
| H72A207 |
| HMS2089C10 |
| HSDB 3289 |
| IV Apomorphine |
| Ixense |
| J-018414 |
| L-Apomorphine |
| LS-21474 |
| LS-61218 |
| MCULE-1576765478 |
| MCULE-3200317958 |
| MolPort-003-983-404 |
| N-Methylnorapomorphine hydrochloride |
| N21FAR7B4S |
| NCGC00025349-01 |
| NCGC00025349-02 |
| NCGC00025349-03 |
| NCGC00025349-04 |
| NCGC00025349-05 |
| NH001 |
| NSC 11442 |
| NSC-11442 |
| NSC11442 |
| PDSP1_000780 |
| PDSP2_001488 |
| pomorphini hydrochloridum |
| Prestwick_28 |
| Prestwick0_000101 |
| Prestwick1_000101 |
| Prestwick2_000101 |
| Prestwick3_000101 |
| Q-200645 |
| R-(-)-Apomorphine |
| R-(-)-apomorphine HCl |
| R-(-)-Apomorphine hydrochloride |
| R( C)-10,11- paragraph signthornoC>>u degrees centAEO.E |
| R( C)-APO |
| SCHEMBL8524 |
| SCHEMBL8541 |
| SKYZYDSNJIOXRL-BTQNPOSSSA-N |
| SMP1_000027 |
| SPBio_002021 |
| SR-01000597777 |
| SR-01000597777-1 |
| STOCK1N-03149 |
| Tocris-2073 |
| Tox21_110967 |
| Tox21_110967_1 |
| UNII-9K13MD7A0D |
| UNII-N21FAR7B4S |
| Uprima |
| Uprima (TN) |
| VMWNQDUVQKEIOC-CYBMUJFWSA-N |
| VR-040 |
| VR-400 |
| VR004 |
| WLN: T C6666 1A Q KN & TT & J DQ EQ K1 & GH |
| ZINC9073 |
US Patents and Regulatory Information for APOKYN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Us Worldmeds | APOKYN | apomorphine hydrochloride | INJECTABLE;SUBCUTANEOUS | 021264-001 | Apr 20, 2004 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Us Worldmeds | APOKYN | apomorphine hydrochloride | INJECTABLE;SUBCUTANEOUS | 021264-002 | Apr 20, 2004 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
or, see our see our flat-rate plans
or, see our see our flat-rate plans
